EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSMMMG00000015203
Gene Symbol: DHCR24
3 Cross references
208 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 8

Ensembl ID : ENSMMMG00000005479
Gene Symbol: LOC107142356
2 Cross references
102 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSMMMG00000001547
Gene Symbol: HMGCR
3 Cross references
270 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSMMMG00000008774
Gene Symbol: PDPK1
3 Cross references
240 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase

Ensembl ID : ENSMMMG00000001016
Gene Symbol: HPD
3 Cross references
202 Possible Orthologues:

40s Ribosomal Protein S29

Ensembl ID : ENSMMMG00000001208
Gene Symbol: LOC107136033
2 Cross references
169 Possible Orthologues:

40s Ribosomal Protein S4-Like

Ensembl ID : ENSMMMG00000009294
Gene Symbol: LOC107139821
2 Cross references
196 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSMMMG00000008808
Gene Symbol: NT5E
3 Cross references
247 Possible Orthologues:

5-Hydroxytryptamine Receptor 1a

Ensembl ID : ENSMMMG00000002451
Gene Symbol: HTR1A
3 Cross references
147 Possible Orthologues:

5-Hydroxytryptamine Receptor 1b

Ensembl ID : ENSMMMG00000005994
Gene Symbol: HTR1B
3 Cross references
245 Possible Orthologues:

5-Hydroxytryptamine Receptor 1e

Ensembl ID : ENSMMMG00000009210
Gene Symbol: HTR1E
3 Cross references
155 Possible Orthologues:

5-Hydroxytryptamine Receptor 1f

Ensembl ID : ENSMMMG00000016369
Gene Symbol: HTR1F
3 Cross references
145 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).